Press Releases

28th March 2025

Ultromics Introduces AI-Powered Probability Scoring on EchoGo® Heart Failure for Enhanced HFpEF Diagnosis

12th December 2024

CMS Updates Final Outpatient Clinical APC Rule for Ultromics’ EchoGo® Heart Failure

20th November 2024

Ultromics obtains Breakthrough Device FDA clearance for its Cardiac Amyloidosis screening device through the Total Product Lifecycle Advisory Program

30th July 2024

Study Confirms AI-Based Detection of HFpEF is Linked to Cardiac Outcomes

9th July 2024

EchoGo® Featured in Hot Line and Late-Breaking Science Sessions at ESC Congress 2024

2nd July 2024

Ultromics granted CPT III reimbursement code for EchoGo® Heart Failure

9th January 2024

Ultromics announces partnership to expedite development of Echo AI algorithm for earlier detection of cardiac amyloidosis

7th November 2023

CMS publishes final Clinical APC rule for Ultromics EchoGo® Heart Failure

2nd August 2023

New Technology Add-On Payment (NTAP) for Ultromics: Advancing HFpEF Diagnosis

31st July 2023

Study Confirms Ultromics’ AI Can Improve HFpEF Detection Using a Single Echocardiogram View

5th July 2023

CMS Establishes HCPCS code for Ultromics EchoGo® Heart Failure, Accelerating Access to Precision HFpEF Detection

26th April 2023

Press releases

Ultromics Introduces AI-Powered Probability Scoring on EchoGo® Heart Failure for Enhanced HFpEF Diagnosis

CMS Updates Final Outpatient Clinical APC Rule for Ultromics’ EchoGo® Heart Failure

Ultromics obtains Breakthrough Device FDA clearance for its Cardiac Amyloidosis screening device through the Total Product Lifecycle Advisory Program

Study Confirms AI-Based Detection of HFpEF is Linked to Cardiac Outcomes

EchoGo® Featured in Hot Line and Late-Breaking Science Sessions at ESC Congress 2024

Ultromics granted CPT III reimbursement code for EchoGo® Heart Failure

Ultromics announces partnership to expedite development of Echo AI algorithm for earlier detection of cardiac amyloidosis

CMS publishes final Clinical APC rule for Ultromics EchoGo® Heart Failure

New Technology Add-On Payment (NTAP) for Ultromics: Advancing HFpEF Diagnosis

Study Confirms Ultromics’ AI Can Improve HFpEF Detection Using a Single Echocardiogram View

CMS Establishes HCPCS code for Ultromics EchoGo® Heart Failure, Accelerating Access to Precision HFpEF Detection

Ultromics granted FDA Breakthrough Device Designation for AI-enhanced Cardiac Amyloidosis detection

Coverage

Can AI give radiology the urgent jump-start it needs?

Startups Seek to Unravel Cardiovascular-Disease Mysteries in Covid-19

How AI could help health providers diagnose COVID-19

Covid-19 has presented the possibility of reinventing healthcare delivery

Ultromics scores $10M for its cardiac decision support tool

Ultromics AI platform to expand trials to 20 NHS hospitals

FDA Clears AI-powered Cardiac Echo Analysis and Quantification by Ultromics

AI transformation in a post-pandemic world

Ultromics on BBC NEWS

Artificial intelligence 'to diagnose heart disease'

The Young BioTech Entrepreneurs Bringing Grey Hair Into The C-Suite

Artificial intelligence will improve medical treatments

Curious about upcoming research and innovation?